Product Program year 2025 Source: CMS Open Payments

Stravix Mesh

Biological Extra Cellular Matrix

Open in the dashboard

General payments

$68,371

583 payments

Research payments

$0

0 payments

Through program year 2025, $68,371 in general payments and $0 in research payments were reported against Stravix Mesh (Extra Cellular Matrix).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $68,371 583

Breakdown

Who paid General payments · program year 2025
  1. Smith+Nephew, Inc. $68,371 583 payments
Top recipients General payments · program year 2025
  1. Navid Pourtaheri Plastic Surgery · Petaluma, CA $8,524 12% · 3 payments
  2. Matthew Varacallo Sports Medicine · Du Bois, PA $7,800 11% · 1 payment
  3. Robert Davis Podiatrist · Bridgeport, CT $6,057 9% · 3 payments
  4. Mario Leyba Surgery · Albuquerque, NM $5,500 8% · 1 payment
  5. Steven Regal Orthopaedic Surgery · Pittsburgh, PA $3,188 5% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Podiatrist $14,633 23% · 87 practitioners
  2. Podiatrist, Foot & Ankle Surgery Podiatrist $11,518 18% · 124 practitioners
  3. Plastic Surgery $9,859 15% · 14 practitioners
  4. Surgery $9,122 14% · 18 practitioners
  5. Sports Medicine Orthopaedic Surgery $7,859 12% · 2 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $25,714 38% · 163 recipients
  2. California $8,524 12% · 1 recipient
  3. Connecticut $6,057 9% · 1 recipient
  4. New Mexico $5,904 9% · 3 recipients
  5. Delaware $5,485 8% · 18 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

583 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record